期刊文献+

人巨细胞病毒包膜糖蛋白gB/AD-1片段的基因克隆和原核表达

Gene Cloning and Prokaryotic Expression of Human Cytomegalovirus Glycoprotein gB/AD-1
下载PDF
导出
摘要 目的克隆人巨细胞病毒包膜糖蛋白gB/AD-1片段并构建其原核表达系统。方法用PCR法从人巨细胞病毒AD169株基因组DNA中扩增gB/AD-1片段并克隆至pGEM-T载体,酶切后,亚克隆至表达载体pET-15b,构建重组表达质粒pET-15b/gB/AD-1,并转化大肠杆菌,IPTG诱导表达。表达产物经金属螯合层析一步纯化,并用Westernblot鉴定。结果gB/AD-1蛋白表达量达到35%。表达产物经纯化后,纯度大于95%。经Westernblot检测,表达产物与CMV阳性人血清发生特异性反应。结论已成功构建重组表达载体pET-15b/gB/AD-1,并在大肠杆菌中高水平表达gB/AD-1。 Objective To clone the gene fragment gB/AD-1 encoding the glycoprotein of human cytomegalovirus(HCMV) and construct its prokaryotic expression system. Methods Amplify gB/AD-1 gene fragment from the genomic DNA of HCMV AD169 strain and clone into vector pGEM-T, then, after identification by sequencing, subclone to expression vector pET-15 b. Transform the constructed recombinant plasmid pET-15b/gB/AD-1 to E. coli for expression of gB/AD-1 under induction of IPTG. Purify the expressed product by one-step immobilized metal ion affinity chromatography (IMAC) and identify by Western blot. Results The expressed gB/AD-1 contained 35% of total somatic protein. The purity of expressed product after purification was more than 95%. Western blot showed specific reaction of the expressed product with CMV antibody-positive human serum. Conclusion The recombinant plasmid pET-15b/gB/ AD-1 was successfully constructed,and gB/AD-1 was highly expressed in E. coli.
出处 《中国生物制品学杂志》 CAS CSCD 2006年第6期571-573,共3页 Chinese Journal of Biologicals
关键词 人巨细胞病毒 包膜糖蛋白 抗原决定簇 Human cytomegalovirus Glycoprotein Antigenic domain
  • 相关文献

参考文献9

  • 1Weill D,Lock BJ,Wewers DL,et al.Combination prophylaxis with ganciclovir and cytomegalovirus (CMV) immune globulin after lung transplantation:effective CMV prevention following daclizumab induction.Am J Transplant,2003,3 (4):492-496.
  • 2Marshall GS,Rabalais GP,Britt WJ,et al.Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.J Infect Dis,1992,165 (2):381-384.
  • 3Kropff B,Landini M,Mach M,et al.An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus.J Med Virol,1993,39:187-195.
  • 4Laemmli UK.Cleavage of structural proteins during the assembly of the head of bacteriophage T4.Nature,1970,227:680-685.
  • 5Chou S,Marousek G,Parenti DM,et al.Mutation in region Ⅲ of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.J Infect Dis,1998,178(2):526-530.
  • 6Marshall GS,Rabalais GP,Stout GG,et al.Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity.J Infect Dis,1992,165 (2):381-384.
  • 7Britt WJ,Vugler L,Butfiloski EJ.Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB):use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.J Virol,1990,64 (3):1079-1085.
  • 8Britt WJ,Mach M.Human cytomegalovirus glycoproteins.Intervirology,1996,39:401-412.
  • 9Britt WJ,Jarvis MA,Drummond DD,et al.Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.J Virol,2005,79(7):4066-4079.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部